FDA Approved Daytime Device for Treatment of OSA
The US Food and Drug Administration (FDA) has approved a prescription-only daytime device for the treatment of mild obstructive sleep apnea (OSA).
The US Food and Drug Administration (FDA) has approved a prescription-only daytime device for the treatment of mild obstructive sleep apnea (OSA).
The eXciteOSA device is designed to be worn during the day to reduce snoring and mile OSA that aims to improve tongue muscle function by delivering electrical muscle stimulation through a mouthpiece that sits around the wearer’s tongue. The eXciteOSA mouthpiece has four electrodes, two located above the tongue, and two located below the tongue. Designed for patients who are 18 years and over, the device is worn for 20 minutes a day, for a period of 6 weeks and once a week thereafter, according to the FDA.
Read more about the device here: fda.gov/news-events/press-announcements.
